| Category : |
Pharmaceuticals and Biochemicals |
 |
| CAS NO : |
608141-41-9 |
| EC NO : |
|
| MF : |
C22H24N2O7S |
| MW : |
460.500214 |
| Specification : |
99% up |
| Packing : |
25kg/drum |
| Product description : |
Description:
Apremilast inhibits an enzyme within your immune system that can affect certain cells and contribute to inflammation in the body. Apremilast is called a PDE4 inhibitor-A reduction in PDE4 activity is thought to help reduce the overactive inflammation that happens in people with plaque psoriasis.Apremilast is used to treat the symptoms of active psoriatic arthritis in adults. Apremilast is also used to treat moderate to severe plaque psoriasis in people who may also receive phototherapy or other treatments for psoriasis. |
| Uses : |
is used to treat the symptoms of active psoriatic arthritis in adults |
| Synonyms : |
N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide;Unii-up7qbp99pn;(S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide;(S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione;CC 10004; |
| Molecular Structure : |
 |